Thursday, May 2, 2024

New model indicates global type 1 diabetes cases could double by 2040 – The Washington Post

Related posts

Using a new model to project the number of people with type 1 diabetes worldwide, members of an international team of researchers estimate up to 17.4 million cases by 2040, double the number people with the disease today.

A study published in the Lancet Diabetes & Endocrinology indicates that 8.4 million people now live with type 1 diabetes, which occurs when the pancreas produces little or no insulin, leading to a buildup of blood sugar that can be disabling or fatal. Symptoms include excessive thirst and urination, blurred vision, exhaustion, dry skin, and unintentional weight loss.

Monitoring has improved in recent years, but type 1 diabetes is underrepresented. Also, since many countries do not collect type 1 diabetes data, the numbers have always been skewed towards North America and Europe.

Learning to live with diabetes

To counter the patchy numbers, the researchers created a model that used available data to predict type 1 diabetes worldwide.

The estimates contradict some myths about the disease, once called childhood diabetes, because its onset often occurs during childhood. Still, the majority of people diagnosed with the disease are between the ages of 20 and 59, and more adults than children are diagnosed each year.

Children, however, are at higher risk of dying from the disease, especially in low-income countries. A 10-year-old child who develops type 1 diabetes in a low-income country has an average remaining life expectancy of just 13 years compared to 61 years in high-income countries, the researchers write.

According to them, around 175,000 people worldwide died from type 1 diabetes in 2021, and 63-70% of deaths among people under the age of 25 occurred because the disease had not been diagnosed.

Better data could help increase the rate of diagnosis, the researchers say.

“There is an opportunity to save millions of lives in the decades to come,” said Graham Ogle, a researcher at the University of Sydney Medical School and one of the study’s co-authors, in a Press release. The figures are a warning, he said, that without solutions – such as universal access to insulin, a better standard of care and awareness of the symptoms of type 1 diabetes – the projection of the team will become a reality.

Related Posts